Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy: A Multicenter, Prospective, Randomized, Double-blind, Non-inferiority Clinical Trial

NCT06717412 is registered in ClinicalTrials.gov with Wang Yusheng as lead sponsor.

NCT NCT06717412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06717412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy: A Multicenter, Prospective, Randomized, Double-blind, Non-inferiority Clinical Trial
Lead sponsor
Wang Yusheng
Phase
Not applicable
Overall status
Recruiting
Start date
November 29, 2024
Completion date
January 31, 2028
Enrollment
146 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity (rop)